Corteva (NYSE:CTVA) Stock Rating Cut to Strong Sell at Zacks Research

Key Points

• Zacks Research downgraded Corteva from “hold” to “strong sell,” contrasting with the broader analyst consensus of “moderate buy,” based on 16 buy, six hold and one sell rating.
• Corteva reported quarterly EPS of $2.30, beating estimates of $2.24, while revenue of $6.38 billion fell short of expectations and declined 1.2% year over year.
• Institutional investors own approximately 81.54% of Corteva, with BlackRock, Wellington Management and Royal Bank of Canada among firms that recently established or increased positions.

Corteva (NYSE:CTVA - Get Free Report) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating in a report issued on Tuesday, Zacks reports.

A number of other research analysts have also recently commented on CTVA. New Street Research set a $17.00 price objective on Corteva in a research note on Monday. Argus reiterated a "buy" rating and issued a $91.00 target price on shares of Corteva in a research note on Friday, September 18th. Mizuho raised their target price on Corteva from $96.00 to $97.00 and gave the company an "outperform" rating in a report on Tuesday, July 14th. Barclays boosted their price target on Corteva from $84.00 to $91.00 and gave the stock an "overweight" rating in a research report on Thursday, June 11th. Finally, Oppenheimer set a $17.00 price objective on shares of Corteva in a research report on Monday. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Corteva presently has an average rating of "Moderate Buy" and an average price target of $67.45.

Corteva Stock Up 4.7%

CTVA stock opened at $14.56 on Tuesday. The company has a 50 day moving average price of $74.30 and a two-hundred day moving average price of $79.19. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. The stock has a market capitalization of $9.72 billion, a P/E ratio of 9.64, a PEG ratio of 0.73 and a beta of 0.57. Corteva has a one year low of $11.74 and a one year high of $90.97.

Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating analysts' consensus estimates of $2.24 by $0.06. The company had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company's quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, sell-side analysts expect that Corteva will post 2.77 EPS for the current year.

Institutional Investors Weigh In On Corteva

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. BlackRock Inc. bought a new stake in shares of Corteva during the 2nd quarter worth $4,560,180,000. Independent Franchise Partners LLP lifted its holdings in shares of Corteva by 1.0% during the fourth quarter. Independent Franchise Partners LLP now owns 10,495,388 shares of the company's stock valued at $703,506,000 after purchasing an additional 107,434 shares during the last quarter. Wellington Management Group LLP lifted its holdings in shares of Corteva by 941.7% during the second quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company's stock valued at $644,720,000 after purchasing an additional 6,881,875 shares during the last quarter. Royal Bank of Canada boosted its position in shares of Corteva by 202.1% in the 1st quarter. Royal Bank of Canada now owns 7,458,624 shares of the company's stock valued at $624,362,000 after purchasing an additional 4,989,371 shares during the period. Finally, Jupiter Topco LLC acquired a new position in shares of Corteva in the 2nd quarter valued at $544,246,000. 81.54% of the stock is currently owned by institutional investors.

Trending Headlines about Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: JPMorgan upgraded Corteva to Overweight from Neutral and set a $19 price target, implying substantial upside from recent trading levels. The firm views the post-spinoff company as undervalued. JPMorgan Upgrades Corteva to Overweight
• Positive Sentiment: KeyBanc also upgraded Corteva to Overweight following the Vylor spinoff. The second bullish rating reinforces the view that the streamlined Corteva may have better growth and valuation prospects. Corteva upgraded at KeyBanc after spinoff of Vylor
• Positive Sentiment: Options activity has surged. Investors purchased 5,408 call options, compared with typical daily volume of 856. While options flow is not a guarantee of future performance, the increase suggests stronger speculative and institutional interest in further gains.
• Positive Sentiment: Recent coverage has highlighted Corteva’s rally after the spinoff and analyst endorsements, including reports that JPMorgan sees as much as 50% upside at current valuations. Corteva Soars on JPMorgan Upgrade
• Neutral Sentiment: Corteva announced that it will release third-quarter 2026 results after the market close on November 11, followed by a webcast on November 12. The announcement provides a future catalyst but contains no new operating results. Corteva Announces Third-Quarter Earnings Date
• Negative Sentiment: One valuation analysis warned that Corteva could be overvalued after its recent advance. That concern may limit additional upside if future earnings do not support the higher valuation. Corteva Valuation Analysis

About Corteva

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company's seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.